Tesla
Dividend Calendar
Stock Rankings
ETF Rankings
Crypto Rankings
4.0
The YieldMax MRNA Option Income Strategy ETF (MRNY) is an exchange-traded fund designed to provide economic exposure to shares of Moderna, Inc. (MRNA) combined with a systematic income-generating options strategy. The ETF is managed by YieldMax Capital, LLC and trades under the ticker MRNY on the Nasdaq.
Classified as a U.S.-only equity ETF employing an active options-based strategy, MRNY seeks to reflect, before fees and expenses, economic exposure to Moderna stock while generating income through call option writing.
MRNY does not replicate a traditional benchmark index. The strategy involves the use of covered call options on Moderna stock, with periodic adjustments carried out according to the fund's rules.
Diversification and sector exposure
MRNY provides concentrated exposure to a single company, Moderna, Inc., which operates in the biotechnology sector and focuses on mRNA-based therapies and vaccines. Sector exposure is therefore linked to biotechnology, reflecting the business activity of the underlying company.
The process seeks to capture income derived from option premiums while simultaneously reflecting the performance of the underlying stock within the strategy’s parameters.
Structure and costs
MRNY shares trade on the secondary market on the NASDAQ throughout regular trading hours. Creation and redemption occur through authorized participants, helping maintain alignment between market price and net asset value.
The fund charges a management fee as outlined in its prospectus and does not apply a performance fee. Its distribution policy may include periodic payments derived from the options-based income strategy.
History and evolution of the ETF
The YieldMax MRNA Option Income Strategy ETF was launched in 2023 during a period of expansion in single-stock options-based ETFs. Since inception, the fund has been used as a vehicle focused on capturing option premiums associated with the volatility of Moderna stock.
Over time, MRNY has reflected both movements in Moderna shares and conditions in the options market, while maintaining systematic implementation of its covered call strategy.
Additional Information
YieldMax MRNA Option Income Strategy ETF (United States) is an exchange-traded fund (ETF), with assets under management totaling $129.16 M.
Over the past 12 months, YieldMax MRNA Option Income Strategy ETF recorded a return of 114.89%, with its price trading between $1.36 and $22.15 during the same period.
The ETF is traded under the ticker MRNY.
